Cell identity is ultimately determined through decoding the genome through the action of gene regulatory mechanisms. In particular, sculpting of the chromatin landscape to reveal unique configurations of gene regulatory elements in each cell type is a major driver of cell identity. Embryonic stem cells (ESCs) represent a dynamic environment in which to study this process and have obvious therapeutic potential in regenerative medicine. We have uncovered several transcription regulators that drive the initial stages of ESC differentiation [1,5]. However, the mechanisms through which they interact with and control the regulatory chromatin environment are not known. Reciprocally, cancer can be viewed as a reversal of the cellular differentiation process, and our recent work on oesophageal adenocarcinoma provides a key demonstration of this type of event . We have begun to understand how transcription factors drive cancer formation through acting on the regulatory chromatin landscape [2,4]. However, it is not clear how different transcription factors contribute to this remodelling. Furthermore, it is unclear how cellular signalling pathways impact on the activity of these regulatory events although we know they play critical roles during normal differentiation and changed roles during tumourigenesis.
Projects are available to further our understanding of how transcription factors, either individually or in combination, interact with the genome to initiate and maintain the activities of gene regulatory elements, in the context of both normal differentiation and also during cell fate changes in cancer. This may reveal new therapeutic opportunities.
Training/techniques to be provided:
Training will be provided in basic biochemical, molecular and cell biological approaches. This will involve cell culture and manipulation using CRISPR technologies, western blotting, recombinant protein production, nucleic acid isolation (eg RNA) and microscopy approaches to image dynamic regulatory events at the single cell level. However, it is important to take genome-wide views of the regulatory events, so bioinformatics training will be provided to analyse and integrate complex datasets. Publically available datasets will be used alongside those generated by the student from a range of possible approaches including RNA-seq, ChIP-seq, ATAC-seq, PRO-seq, Hi-seq, and Capture-C which capture a range of regulatory events ranging to 3D regulatory element rearrangement through to the production of the RNA transcripts.
Candidates are expected to hold (or be about to obtain) a minimum upper second class honours degree (or equivalent) in a related area/subject. Candidates with previous laboratory experience, particularly in cell culture and molecular biology, are particularly encouraged to apply.
How To Apply
For information on how to apply for this project, please visit the Faculty of Biology, Medicine and Health Doctoral Academy website (https://www.bmh.manchester.ac.uk/study/research/apply/). Informal enquiries may be made directly to the primary supervisor. On the online application form select PhD Genetics
For international students, we also offer a unique 4 year PhD programme that gives you the opportunity to undertake an accredited Teaching Certificate whilst carrying out an independent research project across a range of biological, medical and health sciences.
Equality, Diversity and Inclusion
Equality, diversity and inclusion is fundamental to the success of The University of Manchester, and is at the heart of all of our activities. The full Equality, diversity and inclusion statement can be found on the website https://www.bmh.manchester.ac.uk/study/research/apply/equality-diversity-inclusion/”
For international students we also offer a unique 4 year PhD programme that gives you the opportunity to undertake an accredited Teaching Certificate whilst carrying out an independent research project across a range of biological, medical and health sciences. For more information please visit http://www.internationalphd.manchester.ac.uk